Bolstering Protective Glial Cells to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Bex Vision is developing a therapeutic for advanced dry age-related macular degeneration caused by degeneration and death of retinal cells. The company has received a $250,000 SRL to fund the development of a monoclonal antibody therapy.